Clinical Trial Partnerships in Oncology
 Assessing the Landscape of Clinical Trial Design, Planning and Execution for Cancer Therapies

May 19, 2021 | Live Virtual Forum (EST)

Rob Wilson

Research Business Director MindMed

Research Business Director in the digital medicine division of MindMed, a leading psychedelic inspired medicine drug development company. Former Senior VP Business Development and Corporate Strategy for ActiGraph, a leading clinical grade wearable solution. Led Actigraph's strategy and business development in the clinical trial and academic research markets. Former Head of Healthcare Corporate Finance and director of healthcare venture fund relationships at both First Union and RBC Capital Markets for the Royal Bank of Canada. Directed financing for over $3 billion in funding for a wide range of companies in the biotechnology, medical technology, and healthcare service industries.

Agenda May 19 2021

10:50 AM Digital Innovation to Improve Oncology Clinical Trials and Remote Patient Care

Performance status in oncology measures are important to assess and manage cancer patient enrollment and progress during treatment. In this session we will look at a potential improvement in those measures by considering a digital in clinic assessment combined with remote patient measurement tools including wearable sensors, epros, and televisits. Dr. Jorge Nieva from the USC Keck School of Medicine will join the program and talk about an innovative investigator sponsored trial that is planned to provide a real world example of digital innovation and remote patient care.